A recombinant expression vector expressing ll-37 polypeptide, recombinant Lactococcus lactis, antiviral drug, construction method and application

A technology of Lactococcus lactis and LL-37, which is applied in the field of genetic engineering, can solve the problems of low expression efficiency of LL-37, limit the application of LL-37, and high production cost, so as to avoid low expression efficiency and solve the uncertainty of metabolism in vivo sex, the effect of solving cumbersomeness

Active Publication Date: 2021-05-14
INST OF ZOOLOGY CHINESE ACAD OF SCI
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The traditional preparation method of LL-37 is artificial synthesis, but the cost of artificial synthesis is high, which greatly limits the application of LL-37
The prior art discloses the use of genetic engineering methods to prepare LL-37 by constructing recombinant expression vectors containing LL-37 coding genes and recombinant bacteria, but the current methods still have low LL-37 expression efficiency and high production costs. question

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A recombinant expression vector expressing ll-37 polypeptide, recombinant Lactococcus lactis, antiviral drug, construction method and application
  • A recombinant expression vector expressing ll-37 polypeptide, recombinant Lactococcus lactis, antiviral drug, construction method and application
  • A recombinant expression vector expressing ll-37 polypeptide, recombinant Lactococcus lactis, antiviral drug, construction method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] Example 1 Construction of PNZ8149-7×LL-37 expression strain

[0041] 1. The complete sequence of SphI-SPusp45-LEISS-DDDDK-7×LL-37-XbaI was chemically synthesized to obtain the pUC57-7×LL-37 vector;

[0042] 2. Construction of PNZ8149-7×LL-37 vector

[0043] 1) Use the Tiangen plasmid mini-extraction kit to extract the pNZ8149, pUC57-7×LL-37 plasmids;

[0044] 2) Enzyme digestion: PNZ8149, pUC57-7×LL-37 enzyme digestion system is shown in Table 1, the total system is 50 μl, 37 ° C enzyme digestion for 3 hours;

[0045] Table 1 PNZ8149, pUC57-7×LL-37 enzyme digestion system

[0046]

[0047] 3) Preparation of 1% agarose gel electrophoresis, electrophoresis at 120V for 30 minutes, and recovery by cutting the gel;

[0048] 4) Enzyme linkage: the enzyme linkage system is shown in Table 2, the total system is 20 μl, insert fragment:vector = 7:1, overnight at 16°C;

[0049] Table 2 enzyme-linked system

[0050]

[0051] 5) Purification and recovery of the ligated pr...

Embodiment 2

[0052] Example 2 PNZ8149-7×LL-37 Electroporation of Lactococcus lactis NZ3900

[0053] 1. Competent preparation of Lactococcus lactis NZ3900

[0054] 1) Inoculate Lactococcus lactis MG1363 frozen at -80°C into 5ml of M17 liquid medium containing 5% glucose, and culture overnight at 30°C;

[0055] 2) Inoculate the obtained bacterial liquid at 1% in M17 liquid medium containing 2.5% Gly and 5% glucose, culture it statically at 30°C until the OD600 value of the bacterial cell is 0.3-0.4, and collect it for later use;

[0056] 3) Put the above-collected bacterial culture in an ice bath for 10 minutes, centrifuge at 5000 rpm at 4°C for 5 minutes; collect the bacterial cells;

[0057] 4) The precipitate was washed twice with 1 / 10 volume of ice-cold 10% sucrose and 10% glycerol mixed solution, centrifuged at 8000 rpm at 4°C for 5 min, and the precipitate was collected;

[0058] 5) Finally, the precipitate was resuspended in a mixed solution of 1 / 100 volume 10% sucrose and 10% glyce...

Embodiment 3

[0068] Example 3 Silver staining and Western detection of the protein expression ability of the PNZ8149-7×LL-37 expression strain

[0069] 1. Induced secretory expression of PNZ8149-7×LL-37 in Lactococcus lactis

[0070] 1) Introduce the strain into M17 liquid medium, culture it overnight at 30°C, transfer it to a new M17 broth medium the next day, and add the inducer nisin when the OD600 value reaches 0.4-0.6 Nisin continued to culture for 5h;

[0071] 2) Centrifuge at 10,000 rpm for 20 minutes after the culture, take the supernatant, filter the supernatant with a 0.22 μm filter membrane, add N-lauroyl sarcosinate to a final concentration of 0.1%, and keep at room temperature for 15 minutes;

[0072] 3) Add trichloroacetic acid to a final concentration of 7.5%, mix well, and place on ice for 2 hours;

[0073] 4) Centrifuge at 10000rpm for 10min, discard the supernatant, add 2ml tetrahydrofuran, and centrifuge at 10000rpm for 10min;

[0074] 5) Centrifuge at 10000rpm for 10...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a recombinant expression vector expressing LL-37 polypeptide, recombinant Lactococcus lactis, antiviral drug and its construction method and application, belonging to the technical field of genetic engineering; the backbone plasmid used for the construction of the recombinant expression vector is PNZ8149; A fusion gene is inserted into the recombinant expression vector; the nucleotide sequence of the fusion gene is shown in SEQ ID NO:1. The recombinant expression vector of the present invention can be highly expressed in Lactococcus lactis, and the expressed LL-37 can effectively inhibit SARS coronavirus and SARS-CoV2 coronavirus. The present invention also provides a recombinant Lactococcus lactis comprising the recombinant expression vector described in the above scheme. Through the recombinant Lactococcus lactis of the present invention, the antiviral polypeptide drug LL-37 can be orally injected into the human body, and the antiviral effect is good and the production cost is low.

Description

technical field [0001] The invention relates to the technical field of genetic engineering, in particular to a recombinant expression vector expressing LL-37 polypeptide, recombinant Lactococcus lactis, antiviral drugs, construction methods and applications. Background technique [0002] LL-37 is an antimicrobial peptide that also has antiviral activity. The traditional preparation method of LL-37 is artificial synthesis method, but the high cost of artificial synthesis method greatly limits the application of LL-37. The prior art discloses the use of genetic engineering methods to prepare LL-37 by constructing recombinant expression vectors containing LL-37 coding genes and recombinant bacteria, but the current methods still have low LL-37 expression efficiency and high production costs. question. Contents of the invention [0003] The object of the present invention is to provide a recombinant expression vector expressing LL-37 polypeptide, recombinant Lactococcus lact...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/74C12N15/62C12N1/21A61K35/744A61P31/04A61P31/12A61P31/14C12R1/01
CPCA61K35/744A61P31/04A61P31/12A61P31/14C07K14/47C07K2319/02C07K2319/50C12N15/74
Inventor 金万洙张瀚林蒋笑笑郑爱华
Owner INST OF ZOOLOGY CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products